Literature DB >> 11512055

Increased tacrolimus levels during diarrhea.

B W Hochleitner1, C Bösmüller, H Nehoda, M Frühwirt, B Simma, H Ellemunter, W Steurer, E O Hochleitner, A Königsrainer, R Margreiter.   

Abstract

While it is well known that diarrhea results in decreased trough levels of cyclosporin A, experience with levels of tacrolimus (FK506) and diarrhea is limited. We have therefore measured the tacrolimus trough levels of four male and two female recipients of solid organs before, during, and after gastroenteritis. The average age of these six patients was 31 (1-60) years. Four patients had received a kidney transplant, one patient had undergone simultaneous kidney-pancreas transplantation, and another patient had received a liver transplant. Rotavirus was identified in the feces specimen of a 1-year-old child that had undergone liver transplantation. All patients showed an elevated tacrolimus trough level (peak 20-60 ng/ml) after onset of gastroenteritis. Under symptomatic therapy and adequate adjustment of tacrolimus dose, the gastroenteritis stopped and tacrolimus levels returned to the therapeutic range. We recommend that FK506 levels be carefully monitored during diarrhea in order to prevent intoxication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11512055     DOI: 10.1007/s001470100331

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  10 in total

Review 1.  Sex differences in transplantation.

Authors:  Jeremiah D Momper; Michael L Misel; Dianne B McKay
Journal:  Transplant Rev (Orlando)       Date:  2017-02-20       Impact factor: 3.943

Review 2.  Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2015-10       Impact factor: 6.447

3.  Clostridium difficile colitis in solid organ transplantation--a single-center experience.

Authors:  I Stelzmueller; H Goegele; M Biebl; S Wiesmayr; N Berger; W Tabarelli; E Ruttmann; J Albright; R Margreiter; M Fille; H Bonatti
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

4.  Raised tacrolimus level and acute renal injury associated with acute gastroenteritis in a child receiving local rectal tacrolimus.

Authors:  Cheng Hiang Lee; Natalie Tasker; Erik La Hei; Shoma Dutt
Journal:  Clin J Gastroenterol       Date:  2014-04-24

Review 5.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

6.  Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.

Authors:  Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Willy Coosemans; Jacques Pirenne; Yves Vanrenterghem
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  Enterocolitis due to simultaneous infection with rotavirus and Clostridium difficile in adult and pediatric solid organ transplantation.

Authors:  Ingrid Stelzmueller; Silke Wiesmayr; Mirjam Eller; Manfred Fille; Cornelia Lass-Floerl; Guenther Weiss; Paul Hengster; Raimund Margreiter; Hugo Bonatti
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

Review 8.  Clinical aspects of tacrolimus use in paediatric renal transplant recipients.

Authors:  Agnieszka Prytuła; Teun van Gelder
Journal:  Pediatr Nephrol       Date:  2018-02-26       Impact factor: 3.714

Review 9.  Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients.

Authors:  Kwaku Marfo; Jerry Altshuler; Amy Lu
Journal:  Pharmaceutics       Date:  2010-09-09       Impact factor: 6.321

10.  SARS-CoV-2 Infection Can Lead to an Increase in Tacrolimus Levels in Renal Transplant Patients: A Cohort Study.

Authors:  Christopher G Chalklin; Georgios Koimtzis; Usman Khalid; Eliot Carrington-Windo; Doruk Elker; Argiris Asderakis
Journal:  Transpl Int       Date:  2022-03-21       Impact factor: 3.782

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.